Trastuzumab-induced cardiac dysfunction

被引：15
|
作者：
Panjrath, Gurusher Singh
Jain, Diwakar
机构：
[1] Drexel Univ, Coll Med, Nucl Cardiovasc Imaging Lab, Philadelphia, PA 19102 USA
[2] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Internal Med, New York, NY USA
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 2007年 / 28卷 / 02期
关键词：
METASTATIC BREAST-CANCER; PHASE-II TRIAL; INDUCED CARDIOTOXICITY; ADJUVANT CHEMOTHERAPY; MONOCLONAL-ANTIBODY; SAFETY; THERAPY; EFFICACY; HER2; VINORELBINE;
D O I：
10.1097/MNM.0b013e328025ae04
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：69 / 73
页数：5
相关论文
共 50 条
  • [21] Incidence and risk factors of trastuzumab-induced cardiac dysfunction in a predominantly Hispanic South Texas population: a descriptive study
    Sharma, Aditi
    Fierro, Maria E.
    Governor, Samuel
    Kothare, Aishwarya
    Pak, Stella
    Liu, Karen
    Alam, Zuha
    Otchere, Prince
    CARDIO-ONCOLOGY, 2025, 11 (01)
  • [22] A Case Of Trastuzumab-Induced Sarcoidosis
    Ngo, P. T.
    Elsawaf, M.
    Sun, X.
    Greenberg, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [23] Trastuzumab-Induced Hepatotoxicity and Outcomes
    Aregbesola, Eunice
    Oshobu, Ibukunoluwa E.
    Ali, Ahmad
    Rao, Deepthi
    Nale, Hanna
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2935 - S2935
  • [24] Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge
    Tocchetti, Carlo G.
    Ragone, Gianluca
    Coppola, Carmela
    Rea, Domenica
    Piscopo, Giovanna
    Scala, Stefania
    De Lorenzo, Claudia
    Iaffaioli, Rosario V.
    Arra, Claudio
    Maurea, Nicola
    EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (02) : 130 - 137
  • [25] Trastuzumab-Induced Hepatotoxicity: A Case Report
    Vucicevic, Darko
    Carey, Elizabeth J.
    Karlin, Nina J.
    BREAST CARE, 2013, 8 (02) : 146 - 148
  • [26] TRASTUZUMAB-INDUCED EARLY CARDIAC DYSFUNCTION ASSESSED BY SPECKLE TRACKING ECHOCARDIOGRAPHY: CORRELATION WITH CHRONIC INFLAMMATION AND OXIDATIVE STRESS MARKERS
    Dessi', M.
    Mantovani, G.
    Madeddu, C.
    Orgiano, L.
    Alessandra, P.
    Cadeddu, C.
    Antoni, G.
    Serpe, R.
    Mercuro, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 164 - 164
  • [27] Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
    Milano, Gerard A.
    Serres, Emilie
    Ferrero, Jean-Marc
    Ciccolini, Joseph
    CURRENT DRUG TARGETS, 2014, 15 (13) : 1200 - 1204
  • [28] Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
    Zhou, Qiong
    Dong, Jie
    Jiang, Xiaodong
    Pan, Yueyin
    Han, Xinghua
    OPEN MEDICINE, 2020, 15 (01): : 659 - 662
  • [29] Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
    E. J. Reuvekamp
    B. F. Bulten
    A. A. Nieuwenhuis
    M. R. A. Meekes
    A. F. J. de Haan
    J. Tol
    A. H. E. M. Maas
    S. E. Elias-Smale
    L. F. de Geus-Oei
    Journal of Nuclear Cardiology, 2016, 23 : 824 - 832
  • [30] MODULATING CARDIAC AUTONOMIC BALANCE BY VAGUS NERVE STIMULATION ATTENUATES MITOCHONDRIAL DYSFUNCTION AND PROVIDES PROTECTION AGAINST TRASTUZUMAB-INDUCED CARDIOTOXICITY
    Prathumsap, Nanthip
    Ongnok, Benjamin
    Khuanjing, Thawatchai
    Arinno, Apiwan
    Maneechote, Chayodom
    Apaijai, Nattayaporn
    Chunchai, Titikorn
    Arunsak, Busarin
    Shinlapawittayatorn, Krekwit
    Chattipakorn, Siriporn
    Chattipakorn, Nipon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1945 - 1945
12345